ACSL4 upregulated by bone morphogenetic protein 4 (BMP4) enhances the cancer cell fatty acid metabolism, which is associated with acquired drug resistance in EGFR-mutant NSCLC cells [9]. Here, ACSL4 is linked to non-small cell lung carcinoma.